These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 19218281

  • 1. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
    Soon PS, Gill AJ, Benn DE, Clarkson A, Robinson BG, McDonald KL, Sidhu SB.
    Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
    [Abstract] [Full Text] [Related]

  • 2. Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas.
    Creemers SG, van Koetsveld PM, van Kemenade FJ, Papathomas TG, Franssen GJ, Dogan F, Eekhoff EM, van der Valk P, de Herder WW, Janssen JA, Feelders RA, Hofland LJ.
    Endocr Relat Cancer; 2016 Sep; 23(9):727-37. PubMed ID: 27535174
    [Abstract] [Full Text] [Related]

  • 3. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
    Kiiveri S, Liu J, Arola J, Heikkilä P, Kuulasmaa T, Lehtonen E, Voutilainen R, Heikinheimo M.
    Mol Cell Endocrinol; 2005 Apr 15; 233(1-2):47-56. PubMed ID: 15767045
    [Abstract] [Full Text] [Related]

  • 4. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS, McDonald KL, Robinson BG, Sidhu SB.
    Oncologist; 2008 May 15; 13(5):548-61. PubMed ID: 18515740
    [Abstract] [Full Text] [Related]

  • 5. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions.
    Blanes A, Diaz-Cano SJ.
    Hum Pathol; 2006 Oct 15; 37(10):1295-303. PubMed ID: 16949934
    [Abstract] [Full Text] [Related]

  • 6. Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors.
    Soon PS, Libe R, Benn DE, Gill A, Shaw J, Sywak MS, Groussin L, Bertagna X, Gicquel C, Bertherat J, McDonald KL, Sidhu SB, Robinson BG.
    Ann Surg; 2008 Jan 15; 247(1):157-64. PubMed ID: 18156936
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
    Szajerka A, Dziegiel P, Szajerka T, Zabel M, Winowski J, Grzebieniak Z.
    Anticancer Res; 2008 Jan 15; 28(5B):2959-65. PubMed ID: 19031940
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
    De Martino MC, Feelders RA, de Herder WW, van Koetsveld PM, Dogan F, Janssen JA, Waaijers AM, Pivonello C, Lamberts SW, Colao A, de Krijger RR, Pivonello R, Hofland LJ.
    Endocr Relat Cancer; 2014 Aug 15; 21(4):601-13. PubMed ID: 24891456
    [Abstract] [Full Text] [Related]

  • 10. The molecular basis of adrenocortical cancer.
    Lehmann T, Wrzesinski T.
    Cancer Genet; 2012 Apr 15; 205(4):131-7. PubMed ID: 22559973
    [Abstract] [Full Text] [Related]

  • 11. Gene expression profiling of childhood adrenocortical tumors.
    West AN, Neale GA, Pounds S, Figueredo BC, Rodriguez Galindo C, Pianovski MA, Oliveira Filho AG, Malkin D, Lalli E, Ribeiro R, Zambetti GP.
    Cancer Res; 2007 Jan 15; 67(2):600-8. PubMed ID: 17234769
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nestin as a marker in the classification of adrenocortical tumors.
    Lachenmayer A, Lichtenauer UD, Cox T, Schott M, Malendowicz LK, Goretzki PE, Cupisti K, Scherbaum WA, Bornstein SR, Willenberg HS.
    Horm Metab Res; 2009 May 15; 41(5):397-401. PubMed ID: 19294612
    [Abstract] [Full Text] [Related]

  • 14. Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers.
    Wang C, Sun Y, Wu H, Zhao D, Chen J.
    Histopathology; 2014 Mar 15; 64(4):567-76. PubMed ID: 24102952
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors.
    Tacon LJ, Soon PS, Gill AJ, Chou AS, Clarkson A, Botling J, Stalberg PL, Skogseid BM, Robinson BG, Sidhu SB, Clifton-Bligh RJ.
    J Clin Endocrinol Metab; 2009 Nov 15; 94(11):4591-9. PubMed ID: 19820023
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.